I am very grateful to Prof Petra Reinke from Charite/Berlin for the invitation as keynote speaker to the ReShape H2020 Consortium Workshop – this was a great opportunity to highlight how in vivo tracking of engineered cell-based therapeutics can be achieved and why it will be hugely beneficial for the development and translation of more of these very exciting new treatment modalities. Thankfully the meeting was recorded and you can find it here.
